Although genome-wide hypomethylation is a hallmark of many cancers, roles for active DNA demethylation during tumorigenesis are unknown. Here, loss of the APC tumor suppressor gene causes upregulation of a DNA demethylase system and the concomitant hypomethylation of key intestinal cell fating genes. Notably, this hypomethylation maintained zebrafish intestinal cells in an undifferentiated state that was released upon knockdown of demethylase components. Mechanistically, the demethylase genes are directly activated by Pou5f1 and Cebpb and are indirectly repressed by retinoic acid, which antagonizes Pou5f1 and Cebpb. Apc mutants lack retinoic acid as a result of the transcriptional repression of retinol dehydrogenase l1 via a complex that includes Lef1, Groucho2, Ctbp1, Lsd1, and Corest. Our findings imply a model wherein APC controls intestinal cell fating through a switch in DNA methylation dynamics. Wild-type APC and retinoic acid downregulate demethylase components, thereby promoting DNA methylation of key genes and helping progenitors commit to differentiation.
INTRODUCTION
Loss of the adenomatous polyposis coli (APC) tumor suppressor gene is the key initiating step in a model of genetic and epigenetic events that lead to colorectal cancer. Germline mutations in APC result in the development of familial adenomatous polyposis (FAP), a syndrome characterized by early onset of colon cancer (Bienz and Clevers, 2000) . In addition, APC is mutated in more than 85% of sporadic colon tumors (Sparks et al., 1998) . The primary function of APC is attributed to its role in negatively regulating WNT signaling. Mechanistically, APC controls WNT signaling by targeting the transcriptional coactivator b-catenin for proteasomal degradation, thereby preventing its association with the nuclear transcription factor TCF/LEF (Bienz and Clevers, 2000) . The mechanisms underlying APC suppression of tumor formation remain an area of active investigation, with several lines of evidence suggesting that APC serves roles in addition to regulating WNT signaling. Recent reports suggest that APC controls retinoic acid (RA) production which in part relies upon the transcriptional regulator CtBP1 (Phelps et al., 2009b; Nadauld et al., 2006) .
Among the early events proposed to contribute to the development of a variety of cancers, including colorectal cancer, is an apparent genome-wide loss of DNA methylation (Goelz et al., 1985) . A model explaining this hypomethylation includes that DNA methyltransferases fail to maintain normal patterns in highly proliferative cells. Consistent with this possibility, Dnmt1 hypomorph mice show genomic instability and develop T cell lymphomas . Also, suppression of Dnmt1 accelerates loss of heterozygosity of Nf1 in Nf1 +/-p53 +/-(NPcis) mice . These studies argue strongly that Dnmt1-mediated loss of methylation results in chromosomal instability and oncogenesis. Paradoxically, however, there are no reports of DNMT mutation or loss in tumor development. In addition, loss or pharmacologic inhibition of DNMT1 appears to be protective in some circumstances. Notably, adenoma formation after loss of APC is reduced upon pharmacologic or genetic suppression of DNMT1 (Laird et al., 1995; Eads et al., 2002) . This suggests additional regulatory mechanisms linking loss of APC with changes in DNA methylation. Here, we utilize zebrafish in an effort to understand the relationship between APC-dependent aberrant cell fating and a recently described DNA demethylase system (Rai et al., 2008) .
We show that homozygous loss of APC causes robust upregulation of the components of the demethylase and that this impairs the proper differentiation of intestinal cells. Mechanistically, upregulation of the demethylase results from an absence of retinoic acid, a factor that normally suppresses the expression of Cebpb and Pou5f1 (previously known as Oct4), which are direct activators of demethylase components. Genome-wide methylation analyses using methylated DNA immunoprecipitation (MeDIP) identified a panel of key intestinal cell fating genes showing hypomethylation in apc homozygous mutant embryos, a hypomethylation that depended upon demethylase components. Parallel experiments with tissues taken from human subjects showed the demethylation of these same key developmental genes in human colon adenomas. Further, we demonstrate the direct repression of the retinol dehydrogenase (RDH) gene after APC mutation by multiple factors including LEF1, Groucho2/TLE3, LSD1, CoREST, and CtBP1. These findings support interplay between APC, retinoic acid, and DNA demethylase components in regulating intestinal cell fating and suggest misregulation of this interplay as an early event in colon adenoma development after loss of APC.
RESULTS

Loss of APC Upregulates Demethylase Components and Correlates with Demethylation of Key Target Genes
Recently, we proposed a mechanism for active DNA demethylation in zebrafish that involves the cooperative actions of proteins from the cytidine deaminase family (activation-induced deaminase [Aid] and Apobec2), the G:T mismatch-specific glycosylase family (MBD4), and a DNA repair protein family (Gadd45) (Rai et al., 2008) . We have also observed a partially redundant role in demethylation for the Mbd4 paralog Tdg (thymine glycosylase, data not shown), and we therefore include Tdg in our analyses. Given the potential of DNA hypomethylation as an early event after loss of APC, we examined the demethylase components in zebrafish embryos harboring homozygous apc mutations (apc mcr ) that result in a truncated protein similar to those observed in human tumors (Hurlstone et al., 2003) . Remarkably, whole-mount in situ hybridization revealed the robust upregulation of components of the DNA demethylase system, including aid, apobec2a, apobec2b, mbd4, gadd45a, gadd45alike, gadd45b , and gadd45g and slight upregulation of tdg (Figures  1A-1C and Table S1 available online) at 72 hours postfertilization (hpf). We observed no differences in expression of these genes between apc mutants and wild-type embryos prior to 48 hpf ( Figure S1A and data not shown). In addition, homozygous apc mutant embryos show slightly reduced dnmt1 mRNA expression ( Figure 1D and Figures S1B-S1D). By comparison, dnmt4 and dnmt8 appeared to be increased, whereas expression of other dnmts did not change ( Figure S1B ). Although demethylase components were upregulated in apc mutant zebrafish embryos, we did not observe significant changes in bulk DNA methylation (data not shown), which largely monitors repetitive heterochromatin and transposons. To detect genome-wide changes in DNA methylation at promoters, we applied methylated DNA immunoprecipitation (MeDIP) (Weber et al., 2007) , which uses an antibody directed against 5-methyl-cytosine (5meC), followed by hybridization to Agilent 244K oligonucleotide arrays that tile the majority of zebrafish gene promoters (À9 to +2 kb). Analysis of DNA taken from whole embryos uncovered hypomethylation on a number of interesting genes that have been implicated in intestinal fating and development of colorectal cancer, including aldh1a2, hoxa13a, evx1, pitx2, cyclind1, hoxd13a, junbl, frizzled8a, cdx4, sox9b, cyclinb2 , and sox4 (a complete list can be found in Table S2 ). Verification of methylation status for a subset was conducted by qPCR of MeDIP samples ( Figure 1E ) or bisulfite sequencing ( Figure S1E ). To test whether the demethylation of these promoters resulted from the upregulation of the demethylase, we knocked down the demethylase components with morpholino antisense oligonucleotides (hereafter referred to as morpholinos) developed and validated in our previous studies (Rai et al., 2008) . After injection, we noted the reversal of hypomethylation for many genes tested ( Figure 1E ). Interestingly, overexpression of dnmt1 (via mRNA injection at the one-cell stage; protein abundance data can be found in Figure S1C ) largely failed to restore promoter methylation ( Figure 1E ).
Next, we examined the conservation of the above findings in human colon adenomas obtained from FAP patients that harbor germline APC mutations. Consistent with zebrafish embryos, AID, MBD4, and GADD45a were significantly upregulated in at least six out of 11 colon adenoma samples that harbor germline APC mutations ( Figure S1F ). Genome-wide changes in promoter DNA methylation in adenoma samples were assessed from two different FAP patients (compared to normal-appearing colonic tissue) with MeDIP, which revealed significant overlap with promoters affected in apc mutant zebrafish (a complete gene list can be found in Table S3 ). A subset of these regions were tested and verified by qPCR from MeDIP performed in FAP adenoma tissue samples from ten different patients. The promoter regions of CYCLINB2, HOXD13, JUN, PITX2, SOX4, and SOX17 showed demethylation ( Figure 1F ). PITX2 promoter hypomethylation was verified by bisulfite sequencing in adenomas from five different patients ( Figure S1G ).
Regulation of the Demethylation System by Retinoic Acid
Previous studies indicate that APC controls both Wnt signaling and retinoic acid biosynthesis (Phelps et al., 2009a) . To determine whether aberrant demethylase expression resulted from misregulated Wnt signaling or loss of RA production in apc mutant zebrafish, we treated embryos with either all-trans retinoic acid (ATRA) or knocked-down levels of b-catenin by blocking Cox-2 activity with the pharmacological inhibitor (NS-398) (Eisinger et al., 2007) (Figure S2A ). Notably, treatment of apc mutants with ATRA reduced the expression of aid, gadd45a, and mbd4, whereas treatment with NS-398 had little effect (Figures 2A and 2B and Table S4 ). However, RA treatment did not restore dnmt1 expression ( Figure S1D ). Importantly, three additional models of RA deficiency support a role for RA in downregulating the demethylase: rdh1l morphants (Nadauld et al., 2005) , nls mutants (Begemann et al., 2001) and benzaldehyde; an inhibitor of aldehyde dehydrogenases (Russo et al., 1988) ] treated wild-type embryos all showed increased expression of the demethylase genes ( Figure 2C ). Moreover, restroration of RA levels by CtBP1 knockdown in apc mcr embryos led to demethylase downregulation (Figure 2A) . Finally, RA treatment led to repression of AID, MBD4, and GADD45a levels in human colon cancer cell lines (Figure S2B ). Similar to our results after morpholino knockdown of demethylase components, treatment of apc mutant embryos with RA reversed the loss of DNA methylation observed on the panel of genes implicated in intestinal differentiation and proliferation ( Figure 2D ). Taken together, our data provide multiple lines of evidence for robust downregulation of demethylase components by retinoic acid. with aaa Mo (combination of aid, apobec2a, and apobec2b morpholinos; 0.5 ng each) or mbd4 and tdg morpholinos together (1 ng each) or V5-Dnmt1 expressing plasmid (1 pg, an amount that rescues Dnmt1 morphants with 97% knockdown of Dnmt1 levels). Dnmt1 protein levels are in Figure S1C . (F) MeDIP-qPCR for genes shown (selected from genome-wide MeDIP-ChIP microarray analysis) in human adenomas (A) and matching uninvolved tissues (U) from FAP patients. P1-P10 refers to ten different patients. In both (E) and (F), the y axis shows values for each promoter region normalized to a negative control region lacking CpGs and then normalized to the values from wild-type or uninvolved, valued at 1. Error bars indicate ± standard deviation (SD). See also Figure S1 .
Cebpb and pou5f1 Mediate Regulation of the Demethylase Downstream of Retinoic Acid
We have shown previously that, although apc mutant embryos develop primordial intestines expressing key patterning markers such as such as gata6, foxa3, gata5, hnf1b, and hnf4a (Figure S3A) , these intestinal cells fail to differentiate. Differentiation failure results from loss of retinol dehydrogenase (RDH) expression which catalyzes the conversion of dietary retinol into retinaldehyde (Jette et al., 2004; Nadauld et al., 2004; Nadauld et al., 2005) . To better understand the status of RA biosynthesis after apc mutation, we also examined the expression of aldh1a2 (also known as raldh2), which further coverts retinaldehyde into retinoic acid. (We note that zebrafish lack aldh1a1.) ALDH1 is a commonly used marker of normal and cancer stem cells, including those derived from human colon and colon carcinomas (Huang et al., 2009 ). Whole-mount in situ hybridization revealed upregulation of aldh1a2 in apc mutants beginning at 36 hpf that remained elevated through 72 hpf ( Figure 3A and Figures S3B and S3C). This was paralleled by increased aldh1a2 protein levels ( Figure S3D ). The upregulation of aldh1a2 in apc mcr embryos combined with an absence of retinol dehydrogenases (rdh1 and rdh1l) suggested poising of the intestinal progenitor cells for retinoic acid biosynthesis upon production of the required substrate. Indeed, treatment of apc mcr embryos with exogenous retinaldehyde (RAL) partially restored intestinal differentiation marked by fabp2 expression (Mudumana et al., 2004) (Figure 3B ), a result we also observed in rdh1l morphant embryos ( Figure 3C ). Consistent with studies indicating that aldh1a2 expression can be repressed by RA (Dobbs-McAuliffe et al., 2004) (Niederreither et al., 1997) , treatment of apc mutant, rdh1l morphant or nls mutant embryos with RA decreased the expression of aldh1a2 ( Figures S3C, S3E , and S3F).
Since RA can directly repress transcription of pou5f1 in the zebrafish by binding to a RARE in the pou5f1 promoter (Parvin et al., 2008) and since a related POU family transcription factor activates expression of aldh1a1 (Guimond et al., 2002) , we itor NS-398 (10 mM) or injected with control morpholino or ctbp1 morpholino (2 ng). b-catenin knockdown efficiency with NS-398 treatment is depicted in Figure S2A .
(B and C) Quantitative RT-PCR for aid, mbd4, and gadd45a in apc mcr and apc wt embryos treated with DMSO or ATRA (B) or in different RA deficiency models in zebrafish, as shown in (C). Expression of genes are first normalized to 28S and then to the control embryo mRNA/28S ratio, valued as 1.
(D) MeDIP-qPCR for genes shown (as in Figure 1E ) in apc mutants (72 hpf) that are either untreated or treated with ATRA.
Error bars indicate ± SD. See also Figure S2 .
examined the expression of pou5f1 in apc mcr embryos and found it elevated ( Figure 3D ). Furthermore, treatment of apc mcr embryos with RA reduced the expression of pou5f1 (Figure 3D) . Cebpb is another transcription factor upregulated in apc mutants and downregulated by RA treatment ( Figure 3D ) . Since components of the demethylase complex contain OCT and CEBP sites in their promoter, we suppressed Cebpb and Pou5f1 levels in apc mutants by injection of morpholinos and observed reduced expression of the demethylase to an extent similar to that elicited by treatment with RA ( Figure 3E and Table S4 ). As a control, we also knocked down Pou2f1a (aka Oct1), Smad4, and Tcf3a/3b and saw no effect ( Figure 3E , Table S4 , and data not shown). To test whether Pou5f1 and Cebpb were sufficient to upregulate these genes, Figure S3 .
we overexpressed each and observed robust upregulation of all demethylase components in multiple tissues (Figure 3F and Figures S3G and S3H) . Knockdown of pou5f1 also caused a significant reduction in the aldh1a2 expression in apc mutants as measured by whole-mount in situ and quantitative RT-PCR ( Figures S3I and S3J) . Notably, gadd45a and aid promoters contain adjacent and partially overlapping OCT and CEBP recognition sequences at +400 and À1300 position from their respective transcription start sites (TSSs). To assess binding, we performed chromatin immunoprecipitation (ChIP) after the expression of tagged derivatives in 56 hpf embryos. Here, Pou5f1 enrichment was readily detected on both aid and gadd45a promoters when overexpressed ( Figure 3G ). Significant Cebpb enrichment was detected when Cebpb was overexpressed along with a small amount of pou5f1 morpholino ( Figure 3G) ; however, without pou5f1 morpholino, Cebpb enrichment was $2-fold. It is possible that Pou5f1 sterically hinders binding of exogenous Cebpb. These data suggest that both Pou5f1 and Cebpb, whose levels are regulated by retinoic acid, are direct positive regulators of demethylase genes.
The Demethylase System Helps Maintain Intestinal Epithelial Cells in an Undifferentiated State after Loss of Apc As shown above, apc mutant embryos expressed high levels of aldh1a2, a marker of colon crypt progenitor cells, (Figures  3A and 4A and Table S5 ) (Huang et al., 2009) . Further, the aldh1a2 promoter was hypomethylated in apc mutant embryos ( Figure 1E ), and this hypomethylation relied on demethylase components ( Figure 1E ). In examining intestine-specific effects, we noted that cross-sections of whole-mount in situ-stained embryos revealed clear upregulation of aid (52 hpf) and mbd4 (72 hpf) within the intestine of apc mutants ( Figure 4B ). Further, we generated an apc mutant line carrying gut-specific GFP driven by the foxa3 promoter and used these to sort and enrich gut cells from whole embryos. Sorting of GFP-positive cells resulted in approximately 11-fold enrichment based on RT-PCR analysis of fabp2 expression in parallel wild-type embryos ( Figures S4A and S4B) . Analysis of DNA isolated from GFPselected cells demonstrated specific demethylation of aldh1a2, hoxa13a, hoxd13a, cyclind1, and pitx2 in apc mutants compared to siblings ( Figure 4C ). Given these intestine-specific effects, we tested whether the demethylase components were required for maintaining the undifferentiated progenitor population in apc mutants. Notably, knockdown of demethylase components, but not of Pou2f1a, Tcf3a/3b, or Smad4 (as controls), in apc mutant embryos reduced expression of aldh1a2 as determined both by whole-mount in situ hybridization and RT-PCR (Figure 4A , Figure S4C , Table S5 , and data not shown), an effect that was paralleled by increased intestinal differentiation assessed by fabp2 expression ( Figure 4A , Figure S4C , and Table S5 ). Interestingly, analysis of DLD1 and HT29 colon cancer cell lines showed increased expression of AID, MBD4, and GADD45a in ALDH-positive cells (colon stem cells) in comparison to ALDH negative fractions ( Figure S4D ).
We observed a clear affect on the expression pattern of hoxa13a; wild-type embryos restrict hoxa13a expression to the distal tip of the gut, whereas expression is observed throughout the gut in apc mutants. Strikingly, knockdown of demethylase components restores proper spatial expression of hoxa13a in apc mutant embryos ( Figure 4A and Table S5 ). Furthermore, hoxa13a was hypomethylated in apc mutant guts in a demethylase-dependent manner (Figures 1E and 4C) . Finally, overexpression of dnmt1 did not affect expression of these markers (Figure 4A) , focusing the causal affect on the upregulation of the demethylase rather than the possible downregulation of dnmt1.
The above studies in embryos suggested a model wherein retinoic acid-mediated suppression of the DNA demethylase system is essential for intestinal differentiation. Next, we examined the impact of retinoic acid deficiency in the adult zebrafish intestine via treatment for 7 days with DEAB to inhibit retinoic acid biosynthesis. This treatment caused a profound conversion of intestinal cells to a proliferative phenotype as assessed by PCNA staining and incorporation of BrdU ( Figure 4D ). Treatment of adults with both DEAB and ATRA restored normal proliferation and confirmed the specificity of the DEAB treatment ( Figure 4D ). Consistent with our findings in embryos, intestines from DEABtreated adults showed increased expression of aid, gadd45a, mbd4, aldh1a2, and cyclinD1, with fabp2 levels coincidently reduced ( Figure 4E and Figure S4E ). Consistent with these changes in expression, intestinal cells from the DEAB-treated adults showed demethylation of aldh1a2, hoxa13a, hoxd13a, cyclind1, and pitx2 ( Figure 4F ).
The Demethylase Governs Cell Proliferation in the Brain after Apc Loss
The impact of the demethylase system extends beyond intestinal differentiation, as clear effects on brain proliferation were observed in apc mutants. First, we observed high levels (by in situ staining) of pcna, cyclind1, and pitx2 (which activates cyclind1) within brain of apc mutants, which was greatly attenuated by knockdown of demethylase components but not through ectopic dnmt1 expression ( Figure S4F and Table S5 ). Furthermore, increased pcna and cyclind1 expression depended on Pitx2 ( Figure S4F ). As with the gut, primordial brain markers appeared to be normal in apc mcr embryos and ruled out gross patterning defects in accounting for the observed phenotypes ( Figures S4G and S4H ).
Lef1 and Groucho2 Directly Repress rdh1l and Suppress Intestinal Differentiation Next, we sought to determine the mechanism of RDH repression upon apc mutation to better understand the regulation of RA production. The RDH promoter in both humans and zebrafish contains numerous TCF/LEF binding sites, and apc mcr embryos expressed aberrantly high levels of lef1 and its coregulator, groucho2, but not of tcf4 or groucho3 ( Figure 5A and Figure S5A ). Remarkably, knockdown of Lef1 in apc mcr embryos improved many of the overt morphological defects present in apc mcr embryos, including intestinal and pancreatic differentiation, but not eye-differentiation defects ( Figure 5B , Figures S5B-S5F, and Table S6 ). Knockdown of either Lef1 or Groucho2 ( Figure S5G ) was accompanied by the induction of rdh1l expression within the intestine ( Figure 5B and Table S6 ). Importantly, Lef1 directly regulates rdh1l expression, as ChIP experiments revealed a 7.4-fold enrichment of Lef1 on the rdh1l promoter (second and the third Lef1 binding sites upstream of the TSS, Figure 5C ) in apc mcr embryos compared to their wild-type siblings ( Figure 5D ). Coinjection of both lef1 and groucho2
mRNA, but not either alone, reduced expression of fabp2 in the intestine of 80 hpf wild-type zebrafish embryos ( Figure 5E and Table S6 ). The expression of gata6, a marker of primordial gut, was unaffected by injection of lef1 and groucho2 mRNA, thereby eliminating the possibility that the intestine failed to develop ( Figure 5E ). Retinoic acid production in APC mutant human cells is b-catenin independent , Phelps et al., 2009a , 2009b , and we reinforce this by showing that reduction in b-catenin levels by morpholino knockdown or pharmacological inhibition of Cox-2 (an upstream regulator of b-catenin) did not change levels of rdh1l or fabp2 in apc mcr zebrafish embryos ( Figures S5H-S5J) . Surprisingly, and consistent with data presented here, Lef1 levels remained unchanged upon b-catenin knockdown but were rescued upon reintroduction of APC ( Figures S5J-S5K ). Human LEF1 physically interacts with Groucho/TLE family members in the absence of WNT signaling. Notably, human LEF1 and TLE3 (a homolog of Groucho2) showed robust interaction by coimmunoprecipitation (Figure 6A ) and, similarly, zebrafish Lef1 and Groucho2 interacted (data not shown) in SW-480 cells, which harbor an APC mutation. A role for LEF1 and TLE3 overexpression may extend to human samples, as they were each significantly upregulated in 50%-60% of the ten adenoma samples tested ( Figures S6A and  S6B ). Next, we analyzed roles of LEF1 and Groucho2/TLE3 in repressing retinol dehydrogenase expression in three colon Figure S5 .
cancer cell lines harboring APC mutations: DLD1, HT29, and SW480. LEF1 and TLE3 were knocked down with short interfering RNAs (siRNAs), which significantly reduced their respective expression ( Figures S6C and S6D ) and restored DHRS9 (previously known as RDHL) expression in all three cell lines (Figure 6B ). These data strongly support roles of LEF1 and TLE3 together in repressing RDH expression in zebrafish and humans.
LEF1/TLE3 Represses Retinol Dehydrogenase through
Recruitment of the CtBP1/LSD1 Corepressor Complex CtBP1 appears to suppress retinol dehydrogenase (RDH) expression in colon cancer cell lines and in apc mcr zebrafish . It has been shown to exist in a multiprotein repressor complex that includes the histone demethylase LSD1 and the scaffold CoREST (Shi et al., 2003) . Interestingly, immunoprecipitation of TLE3 from SW480 cells efficiently coprecipitated CtBP1 ( Figure 6C ) and LSD1 ( Figure 6D ). Furthermore, LEF1 coprecipitated LSD1, suggesting that CtBP1/LSD1 complex can interact with both LEF1 and TLE3 ( Figure 6E ). Next, we tested whether these interacting proteins can occupy the DHRS9 promoter. To test this, we performed ChIP of CtBP1 and LSD1 on the DHRS9 promoter in SW480 cells, which revealed significant enrichment of CtBP1 and LSD1 on the DHRS9 promoter region containing LEF1 sites ( Figure 6F ). Furthermore, CtBP1 and LSD1 occupancy of the DHRS9 promoter was reduced in cell lines treated with LEF1 siRNA, suggesting that LEF1 helps in recruitment of CtBP1 complex to DHRS9 promoter ( Figure 6G ). Also, knockdown of LSD1 by siRNA was sufficient to restore DHRS9 levels in DLD1, HT29, and SW480 cells ( Figure 6H and Figure S6E ). Moreover, inhibition of LSD1 enzymatic activity by treatment with pargyline (Shi et al., 2004 ) also upregulated DHRS9 expression in all three cell lines ( Figure 6H ). Finally, knockdown of CoREST also restored DHRS9 expression in the same three cell lines (Figure 6H and Figure S6F ). Taken together, these data suggest that a LEF1/TLE3 module binds to the retinol dehyrogenase promoter and recruits the CtBP1/LSD1/CoREST complex for repression.
LSD1 and CoREST Are Upregulated in APC Mutant
Tissues and Repress DHRS9 CtBP1 protein levels are elevated in APC mutant cells , as they lack APC-and proteasome-mediated CtBP1 destruction. We tested LSD1 protein levels in FAP polyps.
Immunostaining on cross-sections of FAP colonic adenomas showed upregulation of both LSD1 and CtBP1 compared to matched normal mucosa samples ( Figure S6G ). Western blot further confirmed upregulation of LSD1 protein in FAP polyps compared to matched normal tissue ( Figure S6H ). Here, unlike CtBP1, and similar to LEF1 and TLE3, LSD1 transcript levels were upregulated in multiple adenoma tissues by RT-PCR analysis ( Figure S6I ). Next, we tested whether LSD1 and CoREST function in intestinal differentiation and retinol dehydrogenase regulation using zebrafish. Immunoblot analysis revealed Lsd1 and Ctbp1 protein upregulation in apc mcr zebrafish embryos ( Figure S7A ). Similar to adenomas, the transcript levels of Lsd1 and Corest are also upregulated in apc mcr zebrafish embryos at 80 hpf, as examined by whole-mount in situ staining ( Figure 7A ) and verified by RT-PCR ( Figure S5A ). Importantly, knockdown of Lsd1 and Corest rescued the expression of intestinal rdh1l in apc mcr embryos (Figure 7B and Figures S7B and S7C) . Furthermore, rescue of rdh1l expression was accompanied by restoration of intestinal differentiation (fabp2), but not retinal differentiation (irbp) (Figure 7C) . Treatment of apc mcr zebrafish embryos with pargyline also rescued expression of rdh1l ( Figure 7B ) and fabp2 ( Figure 7C ), suggesting that the catalytic activity of Lsd1 is essential for this regulation in zebrafish. These data suggest that Lsd1 and Corest are required to maintain the repression of rdh1l and the undifferentiated status of the intestines of apc mcr zebrafish embryos.
DISCUSSION
Genomic hypomethylation was proposed by Holliday as an oncogenic mechanism nearly 25 years ago (Holliday and Jeggo, 1985) . Since then, many studies have focused on DNA methyltransferases and the paradoxical hypermethylation of tumor suppressor genes that occurs in the background of genome-wide hypomethylation. Mechanisms explaining the underlying hypomethylation, its contribution to tumor initiation and progression, and its relationship to genetic events are largely unknown. Here, we present a model linking APC loss-a key genetic determinant of colon adenoma development-with the misregulation of DNA methylation dynamics through activation of a DNA demethylase system. This dynamic regulation appears to be critical to the proper fating of intestinal cells in zebrafish and targets key regulators of cell maintenance and differentiation. Mechanistically, loss of APC results in Figure S7 .
suppression of retinoic acid biosynthesis due to repression of RDH by aberrant upregulation of a transcriptional complex including LEF1, Groucho2/TLE3, CtBP1, LSD1, and Corest. Downstream of retinoic acid loss, the transcriptional regulators Pou5f1 and Cebpb appear to be required for activation of the demethylase components ( Figure 7D ).
Recent studies have confirmed the involvement of AID in DNA demethylation during reprogramming of human cells (Bhutani et al., 2010) and in the erasure of DNA methylation from mouse primordial germ cells (Popp et al., 2010) . Our data offer a new mechanistic explanation for previous studies implicating DNA hypomethylation in cancer development (Goelz et al., 1985) . Other models have considered the possibility that genomewide demethylation during tumorigenesis results from the inability of DNA methyltransferases to maintain normal DNA methylation patterns in highly proliferative cells. Interestingly, we observed a loss of dnmt1 in parallel with upregulation of the demethylase system in apc mutant zebrafish embryos. However, unlike knockdown of the demethylase components, injection of dnmt1 into apc mutants failed to restore intestinal differentiation and methylation on specific genes. This finding suggests a major role for the misregulation of the demethylase, rather than Dnmt1 loss, in maintaining the progenitor-like state of intestinal cell present in apc mutants. Consistent with this model, knockout of Apobec-1, a mammalian 5meC deaminase highly related to AID (Morgan et al., 2004) , reduced adenoma formation in the Apc Min mouse model (Blanc et al., 2007) .
Our work also provides insight into an apparent contradiction brought about by previous studies indicating that genetic loss or pharmacologic inhibition of DNMT1 appears protective in some circumstances (Eads et al., 2002; Laird et al., 1995) . It is important to note that the demethylase system works through a process that first involves deamination of 5meC to thymine and that it may therefore enhance C to T transitions. It is possible that loss of methylation due to DNMT1 inhibition lowers the yield of deamination products (5meC/T transitions) by removing the substrate, 5meC. This could in turn slow adenoma progression by limiting this mode of mutation. Interestingly, Laird et al. speculated reduced mutation rates in the Apc Min mice treated with 5-Aza-cytidine as this treatment effectively prevented adenoma initiation but failed to affect established polyps (Laird et al., 1995) . Similarly, knockout of MBD4 increases intestinal tumorigenesis in parallel with increased rates of C to T transitions (Millar et al., 2002) .
Although the transcriptional effects of retinoic acid in controlling cell patterning, fate, and differentiation are well documented, the regulation of RA production as a determinant of cell fate decisions is less well understood. Production of retinoic acid requires converting dietary retinol (vitamin A) into retinoic acid, a process that occurs via two enzymatic steps (Duester, 2000) : the conversion of retinol into retinal by alcohol dehydrogenases (ADHs) and short-chain dehydrogenases (SDRs), followed by the conversion of retinal into retinoic acid via aldehyde dehydrogenases (ALDHs) (Duester, 2000) . Studies in mice and chickens indicated that RALDHs, rather than RDHs, represent the primary point for regulating tissue-specific production of retinoic acid (Duester et al., 2003) . Recent studies in zebrafish, however, have demonstrated that Rdh1 and Rdh1l are essential for intestinal differentiation and the development of the pectoral fin, jaw, eye, and exocrine pancreas (Nadauld et al., 2004; Nadauld et al., 2005) . Our findings here provide a model suggesting a dynamic inverse relationship between RDHs and ALDHs in regulating RA production in intestinal cells. In this model, high levels of ALDH appear to poise cells for RA production upon generation of RAL by RDH. This, in turn, initiates a program of differentiation that relies in part on the suppression of the demethylase system ( Figure 7E) .
Interestingly, we show that multiple transcriptional repressors, namely LEF1, Groucho2/TLE3, CtBP1, LSD1, and CoREST, work together to repress the production of retinoic acid by direct binding to, and repression of, the rdh1 promoter. Further, the activity of LSD1 is required for maintaining repression of the RDH promoter in the presence of APC mutation. Consistent with the model, knockdown of these proteins restored rdh1l expression and intestinal differentiation to apc mutants. Furthermore, our data indicate that APC regulation of RDHs and the demethylase system occurs independently of b-catenin, thereby revealing a novel role for LEF1, which is known to be upregulated in sporadic colon carcinomas (Hovanes et al., 2001 ) but thought previously to act primarily through an interaction with b-catenin. Consistent with this idea, human FAP adenoma tissues also showed increased levels of all of these factors. Taken together, these data support a model wherein mutations in APC cause upregulation of LEF1, Groucho2/TLE3, CtBP1, LSD1, and CoREST and that this complex serves to repress intestinal differentiation by directly targeting RDHs.
Our results suggest a mechanism for a rapid and robust changes in DNA methylation dynamics during development, mediated by retinoic acid. We observe a marked upregulation of demethylase components in RA-deficient embryos and a marked downregulation of demethylase components after treatment with retinoic acid. Notably, we demonstrate that retinoic acid antagonizes two key direct activators of demethylase components, Pou5f1 and Cebpb, leading to demethylase downregulation. These results raise the possibility that part of the basis for the developmental plasticity and maintenance of progenitor cells is the DNA methylation dynamics provided by the demethylase system. Loss of demethylase activity upon exposure to retinoic acid may favor the imposition of DNA methylation patterns at the promoters of key developmental regulators, which may help commit cells to differentiation and help maintain that commitment. Further studies will determine the potential roles for other candidate demethylase components downstream of APC.
In summary, we have shown that DNA cytosine demethylases are upregulated in APC mutant human and zebrafish tissue and are responsible for demethylation of genes that are important for maintaining a progenitor cell population in APC mutant tissues. These findings offer a mechanistic model implicating active DNA demethylation in contributing to cell fating defects after loss of APC.
EXPERIMENTAL PROCEDURES Zebrafish Care and Injections
Wild-type (Tu strain), apc heterozygous (kind gift of Anna Pavlina-Haramis and Hans Clevers), and gutGFP adults [Tg(XlEef1a1:GFP) s854 ; obtained from ZIRC] adults maintained in Z-Mods at 28 C in a 14:10 hr light cycle. For all wholemount in situ experiments, embryos were raised in 0.003% phelthiourea (PTU)-treated embryo water to inhibit pigment formation. Morpholinos (Gene-tools), DNA, and RNA were injected at the one-cell stage. Sequences are available in the Extended Experimental Procedures.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridizations were performed as described earlier (Nadauld et al., 2004) . Riboprobes for the indicated genes were made with digoxigenin-labeled UTPs (Roche). Genes were cloned in pCR-II-TOPO vector (Invitrogen).
Cell Culture and Transfection SW480, DLD1, and HT29 cells were purchased from ATCC and grown according to the guidelines of the manufacturer. Transfection experiments were performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. After transfection, cells were incubated for 24 hr (DNA), 48 hr (IP) or 72 hr (siRNA) and then harvested for western blotting analysis, immunoprecipitation, or RT-PCR.
RT-PCR
RNA from whole embryos or human adenoma tissues was isolated with Trizol (Invitrogen). cDNA library was prepared with the Superscript III kit (Invitrogen).
RT-PCR was performed on a Roche light cycler. Primer information is available upon request.
Western Blotting
Protein extracts were made and western blotting was performed as described earlier (Rai et al., 2008) .
Drug Treatments
Embryos were treated with all-trans retinoic acid (1 mM) or DMSO (vehicle) every day starting at 24 hpf for 45 min. NS-398 treatment was similar except at 10 mM. For pargyline treatment, drug (3 mM or water control) was left in embryo water starting at 75% epiboly, and new drug as added every day. Cells were treated with pargyline at 3 mM or all-trans retinoic acid (or DMSO) at 1 mM each day for 2 days, and RNA was isolated.
Methylated DNA Immunoprecipitation and Array Hybridization
The methylated DNA immunoprecipitation (MeDIP) procedure was previously described (Weber et al., 2007) . In brief, Dynabeads (conjugated with sheep anti-mouse secondary antibody, Invitrogen) were incubated with 10 mg 5MeC antibody (Eurogentec) for 2 hr, washed and then incubated with 4 mg of sonicated DNA (300-1000 bp fragments) overnight. Immunoprecipitated DNA was used for qPCR or amplified with whole-genome amplification kit (Sigma Aldrich). After amplification, 2 mg amplified DNA was labeled with Cy5, and 2 mg input DNA was labeled with Cy3 (Bio labs). Samples were competitively hybridized to 244K oligonucleotide promoter arrays (Agilent).
Chromatin Immunoprecipitation
ChIP was performed as described earlier (Rai et al., 2008) . ChIP for Cebpb and Pou5f1 were performed in wild-type (Tu) whole embryos. V5-zfCEBPb (along with pou5f1 morpholino, 80 pg) or V5-zfPou5f1 (both cloned in pcDNA3.1/ nV5 DEST; Invitrogen) was injected at the one-cell stage, and embryos were collected at 48 hpf. ChIP was performed with V5 antibody (Abcam). ChIP for Lef1 was performed with rabbit-anti-zfLef1 antibody in extracts made from apc wt and apc mcr whole embryos collected at 72 hpf. ChIP in SW-480 cells were performed with antibodies a-CtBP (Santa Cruz; sc-11390), a-LSD-1 (Abcam; ab-17721), and rabbit IgG (control).
Coimmunoprecipation
Constructs expressing tagged proteins were transfected in SW480 cells and protein harvested in 13 IPH buffer 48 hr after transfection. Immunoprecipitation was performed as described earlier (Rai et al., 2008 ) with rabbit-a-V5 antibody (Abcam) or a-Myc monoclonal antibody. Western blot was probed with mouse-a-V5 (Invitrogen), mouse-a-GFP (BD Biosciences), rabbit-a-myc (Santa Cruz), and rabbit-a-V5 (Abcam) antibodies.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven figures, and six tables and can be found with this article online at doi:10.1016/ j.cell.2010.08.030.
